Privacy Policy
Signals Blog

Contributors

Categories

Right Turn: Sugary solution to scientific pickle

Whether you call it cotton candy, candy floss or the original name for it “fairy floss,” I’m going to assume you’ve never called it “a tool for creating artificial blood vessels.” (Too long and not very appetizing.) Nevertheless, Dr. Leon Bellan, Vanderbilt...

Cell Therapy Deal Review: January

Welcome to your Cell Therapy Deal Review for the month of January. Things got off to a quick start with a number of cell-based immunotherapy companies announcing deals and research collaborations out of the gate, including a third acquisition by Juno. Juno...

Series: Spotlight on Cell Therapy

Cell therapy is not a new idea. Bone marrow transplantation—the first ever cell therapy—has been around since the 1950s. Over half a century of research has brought important advancements, yet this technology has struggled to make it to prime time. Understandably,...

Regenerating a broken heart

Samantha is a PhD student in the Chemical Engineering and Applied Chemistry department at the University of Toronto. She has previously investigated regeneration in a non-mammalian gecko model during an MSc program, and now currently combines stem cell biology and...

The enabling technology of polymer design

Another in the series: “What drives research in the field of biomaterials?” “What makes Canada cool?” asks Dan Taekema of The Toronto Star, and among the handful of influential figures that he writes about is the “rock star” researcher, Professor Molly Shoichet. I was...

RoosterBio: Helping researchers scale up cells for patient delivery

John Farrell is a science and technology blogger for Forbes online. John was invited to cover proceedings at the 2015 Till & McCulloch Meetings and this is his third and final report. This blog also appears on Forbes and is reprinted here with permission. One of...